Related Experiment Videos

Melanoma-associated adhesion molecule MUC18/MCAM (CD146) and transcriptional regulator mader in normal human CNS

M J Schwarz1, N Müller, D Körschenhausen

  • 1Department of Neurochemistry, Psychiatric Hospital, University of Munich, Germany mschwarz@psy.med.uni-muenchen.de

Neuroimmunomodulation
|September 8, 1998
PubMed

Insights

Melanoma markers MUC18/MCAM and Mader are expressed in normal CNS tissue. Mader is found on neurons and glial cells, while MUC18/MCAM is on vasculature, suggesting roles in CNS cell adhesion and proliferation.

Area of Science:

  • Neuroscience
  • Oncology
  • Cell Biology

Background:

  • MUC18 (melanoma cell adhesion molecule, MCAM, CD146) and Mader are melanoma progression markers.
  • Neoplastic cells of neuroectodermal origin often express neuron-specific molecules.

Purpose of the Study:

  • To investigate the presence and localization of MUC18/MCAM and Mader in normal adult human CNS tissue.
  • To determine if these melanoma-associated antigens are expressed in the central nervous system.

Main Methods:

  • Immunohistochemistry
  • Immunoblotting
  • Two-dimensional gel electrophoresis

Main Results:

  • Mader protein is preferentially expressed on neurons and glial cells in the CNS.
  • The cell adhesion molecule MUC18/MCAM is primarily expressed on CNS vasculature.
  • These proteins, known melanoma markers, show distinct localization patterns in normal neural tissue.

Conclusions:

  • Mader and MUC18/MCAM are present in normal CNS tissue, with specific cell type and structural localization.
  • Findings suggest potential roles for Mader and MUC18/MCAM in CNS cell adhesion and proliferation control.
  • Further research is warranted to explore their functions within the central nervous system.

Related Concept Videos